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Dear Editor:
Ectodermal dysplasias (ED) encompass nearly 200 differ-
ent genetic conditions identified by the lack, or dysgenesis, 
of at least two ectodermal derivatives, such as hair, nails, 
teeth, and sweat glands. Hypohidrotic/anhidrotic ED (HED) 
is the most frequent form of ED and it can be inherited as 
an X-linked (XL)-HED (MIM 305100), autosomal recessive 
(AR)-HED (MIM 224900), or autosomal dominant (AD)-HED 
(MIM 229490) condition. HED is caused by mutations in 
any of the three ectodisplasin pathway genes: ectodispla-
sin (EDA), which encodes a ligand for the second gene, 
the EDA receptor  (ectodysplasin A-receptor, EDAR), and 
EDARADD, an intracellular signaling for this pathway. 
HED is characterized by a triad of clinical features includ-
ing absent or diminished eccrine sweat glands, missing 
and/or malformed teeth, and thin, sparse hair. It also in-
cludes dryness of the skin, eyes, airways, and mucous 
membranes, as well as other ectodermal defects and, in 
some cases, fever, seizures, and rarely, death.
XL-HED is caused by mutations in the EDA gene, located 
on chromosome Xq12-q13.1, which encodes a signaling 
molecule of the tumor necrosis factor (TNF) superfamily. 
AR- and AD-HED are caused by mutations in the EDAR 
gene, located on chromosome 2q11.q13 or the EDAR-
Associated Death Domain encoding gene, EDARADD, lo-
cated on chromosome 1q42-q431.
Several mutations in the EDA, EDAR, and EDARADD genes 
have been described as causing HED in different popula-
tions. The XL-HED form is the most common and is respon-
sible for 90% of all HED cases2-6.
The three forms of HED are clinically indistinguishable. To 
date, a comprehensive evaluation of HED in the Mexican 
Hispanic population has not been undertaken. In the pres-
ent study, we aimed to characterize the mutations in EDA, 
EDAR, and EDARADD genes present in Mexican Hispanic 
patients with HED.
Male and female patients (35 families) from different geo-
graphical regions of Mexico with features suggestive of HED 
were enrolled in the study (Fig. 1). Index cases and their pa-
rents were screened for missing or malformed teeth, thin or 
sparse hair, and nail changes; all subjects answered ques-
tions about sweating, heat intolerance, fever, seizures, and 
family history of siblings deceased due to unknown fever 
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Fig. 1. Mutations in ectodisplasin (EDA) and ectodysplasin A-receptor (EDAR) genes cause hypohidrotic/anhidrotic ED (HED). (A) Index 
case (arrow) from X-linked pedigree shows multiple male affected offspring. Two of them died of fever during  the first month of birth. 
Mutation analysis revels a homozygous c.1049G＞A, p.G350D mutation. Male and female index cases (arrows) from a family with 
Autosomal Recessive HED. This patient has an heterozygous mutation in Exon 3 c.212 G＞A, p.71 C＞Y. The clinical findings of 
these two patients with HED show a sparse hair, frontal bossing, saddle nose, periocular hyperpigmentation and enlarged lips are evident. 
In our cohort there was no difference between the two forms of inheritance. White symbols indicate unaffected indiviudals, black 
squares and circles denote affected, dots indicate obligate carried females, the propositus are in arrows. (B) X-linked-HED, clinical variability 
in male patients analayzed. They show the clasical triad of HED, dental abnormalities, anhidrosis/hypohirosis and thin sparse hair. 
Some of them has normal hair appaerance and recessive HED female patient with minor clincal aspect of HED.
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Table 1. Mutations identified in 35 Mexican Hispanic families with hypohidrotic ectodermal dysplasia (ED)
Family Exon Coding sequence variant Protein change Mutation type Reference
1 EDA-1 c.106G＞T p.E36Ter Nonsense
2 EDA-1 c.382C＞T p.Q128ter Nonsense Schneider et al.3
3 EDA-3 c.448G＞A p.E150K Missense
4 EDA-3 c.463C＞T p.R155C Missense Vincent et al.4
5 EDA-3 c.467G＞A p.R156H Missense Monreal et al.9
6 EDA-4 c.Del 546-581 p.183-194del Deletion
7 EDA-5 c.574G＞C p.G192R Missense
8 EDA-6 c.793+1 G＞C Splice site
9 ED-A7 Del 887-900 p.297-301delFSx4 Deletion
10 EDA-8 c.894G＞C p.G299R Missense
11 EDA-8 c.911A＞G p.Y304C Missense RamaDevi et al.10
12 EDA-9 c.1037G＞A p.C346Y Missense
13 EDA-9 c.1038C＞G p.C346W Missense
14 EDA-9 c.1049G＞A p.G350D Missense
15 EDA-9 c.1133C＞T p.T378M Missense Schneider et al.3
16 EDAR 3/11 AR-HED* c.212 G＞A p.C71Y Missense Moya-Quiles et al.8
*Autosomic recessive hypohidrotic/anhidrotic ED (HED). EDA ten novel mutations are show in bold. Fifteen mutations in different domains 
of the EDA gene were found. Four non-related families have the same recurrent mutation p.G3650D in the tumor necrosis factor domain.
during the first year of life.
The protocol was approved by the ethics and research 
committees of the University Hospital of the Autonomous 
University of Nuevo Leon (DE 12-007) and Yale University 
School of Medicine. After obtaining informed consent, pe-
ripheral blood of patients and family members was drawn 
and DNA was extracted using a standard phenol-chloro-
form protocol.
All exons of EDA, EDAR, and EDARADD genes were 
screened using specific primers as described by Cluzeau 
et al.2, 2011; polymerase chain reaction amplification was 
performed using Amplitaq Gold (Applied Biosystems, Foster City, 
CA, USA) or Kapa 2G Fast polymerase (Kapa Biosystems, 
Wilmington, MA, USA).
Sequencing reactions were carried out using Big Dye Ter-
minator v3.1 (Applied Biosystems) and resulting DNA frag-
ments were sequenced using the 3130xl Genetic Analyzer 
(Applied Biosystems). Sequencing quality control and as-
sembly were performed using Sequence Scanner V.1.0 
(Applied Biosystems) and Phred, Phrap, and Consed or 
Sequencher software (Gene Codes, Ann Arbor, MI, USA)7.
A total of 40 patients from 35 families were tested for 
EDA, EDAR, and EDARADD mutations. Sequence analysis 
of all coding exons of EDA, EDAR, and EDARADD genes iden-
tified 16 different mutations in 21 (60%) families (Table 1)3,4,8-10.
Sixteen different mutations were present; fifteen mutations 
were found in the EDA gene, 5 had previously been reported, 
and 10 were novel. One known mutation was found in the 
EDAR gene.
No mutations were found in the EDARADD gene in the 
remaining kindreds (14) analyzed. WNT10A analysis was 
not performed.
Upon review of the clinical features in the affected pa-
tients and female carriers, there was no phenotypic corre-
lation with genotype (data not shown). Ten obligate female 
carriers displayed dental abnormalities (one missing tooth) 
that were independent of specific mutations; we speculate 
that this may be due to random X-inactivation.
In studying a Mexican Hispanic Cohort (see results Table 1), 
we have found that 60% bear mutations in EDA or EDAR, 
but not in EDARDD. Of the 16 identified inherited muta-
tions, ten were novel. Of these novel mutations in EDA, 
p.E36ter is a nonsense mutation that produces a truncated 
protein; the other nine missense mutations lie in conserved 
regions of the protein including the furin cleavage site and 
the TNF-like domain where previous disease-causing mu-
tations have been identified. The nonsense mutations 
p.E36ter and p.Q128ter produce a truncated form of the 
ectodisplasin protein, subject to nonsense-mediated decay3. 
Missense mutations p.R150K, p.R155C, and p.R156H dis-
rupt the furin cleavage site, whereas p.G299R, p.C346Y, 
p.C346W, and p.T378M are predicted to disrupt protein 
function4-6.
Two novel deletion mutations were present in this pop-
ulation: c.del 546-581 (p.183-194 del) and c.887-900 del, 
p.297-301delFSx4 as one splice site mutation, c.793＋1 
G＞C.
Thirty-three mutations, mainly missense mutations, EDAR 
gene have previously been reported11. We found a homo-
zygous c.G212A, p.C70Y mutation in exon 3 of EDAR in 
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an affected father-daughter pair with AR HED. This muta-
tion lies within the ligandbinding domain of EDAR and is 
crucial for binding to the ligand8. A novel recurrent muta-
tion p.G350D was found in four kindred, and the pre-
viously reported p.R155C was found in three kindred3. 
This suggests possible independent founder mutations in 
the Mexican Hispanic population.
These first findings in the Mexican Hispanic population 
expand the mutation spectrum in EDA and EDAR in HED, 
and confirm the clinical diagnosis in a large cohort. Recurrent 
mutations suggest possible founder mutations that may aid in 
genetic counseling and prenatal diagnosis in at-risk preg-
nancies. We also found that newborn febrile seizures are 
a significant cause of perinatal lethality, with 8 deaths in 
our cohort. An additional benefit of our study is the identi-
fication of potential candidates for replacement therapy with 
recombinant EDA protein (Edimer Pharmaceuticals, Cambridge, 
MA, USA)12.
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